According to the latest report by IMARC Group, titled “Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the Aerosol Delivery Devices Market is expected to reach a value of US$ 60.14 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.Aerosol delivery devices are handheld, portable drug delivery devices used in treating respiratory disorders, such as asthma, obstructive lung diseases, pulmonary infections and arterial hypertension, and cystic fibrosis. They aid in lessening dosage requirements, reducing systemic adverse effects, and improving the ability of patients to self-administer medication. At present, due to the advent of novel macromolecular medications, smart aerosol delivery devices are finding extensive application in non-respiratory conditions, such as analgesia, diabetes, and Parkinson’s disease.
Global Aerosol Delivery Devices Market Trends:
The rising air pollution levels globally due to rapid urbanization and industrialization are increasing the risk of developing respiratory disorders, such as chronic obstructive pulmonary disease (COPD). This represents one of the key factors driving the market. Besides this, the sudden outbreak of coronavirus disease (COVID-19) that leads to acute respiratory infections among patients is positively influencing the market. Moreover, the leading market players are developing novel aerosol delivery devices that help treat lung infection and chronic inflammation and enhance airway clearance in patients with cystic fibrosis. This, in confluence with the rising demand for personalized drug therapy and the escalating use of online channels for buying medical supplies, is anticipated to strengthen the market growth.
Request Free Sample Report: https://www.imarcgroup.com/aerosol-delivery-devices-market/requestsample
Global Aerosol Delivery Devices Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
The report has segmented the market on the basis on region, product, application, distribution channel.
Breakup by Product:
Dry Powder Inhalers
Single Dose Inhalers
Multi Dose Inhalers
Metered Dose Inhalers
Conventional Pressurized Inhalers
Soft Mist Inhalers
Nebulizers
Jet Nebulizers
Ultrasonic Wave Nebulizers
Vibrating Mesh Nebulizers
Breakup by Application:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis
Non-Respiratory Diseases
Diabetes
Analgesia
Parkinson’s Disease
Breakup by Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Stores
Breakup by Region:
North America:( United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/aerosol-delivery-devices-market
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapp